Recently contacted AZ, both in the US and Europe regarding VVUS. In US, they knew very little about the company, apparently current sales don't encourage much interest. Not on their "radar screens," as they put it, in the US. Europe is a somewhat different story. To date, AZ has launched Muse in a little more than 10 countries. Some near term expected launches include the Netherlands and Spain. Muse is now included as a part of oncology. Marketed along with other drugs in the treatment of prostrate cancer, primarily through urologists.
FWIW: I'm expecting a response shortly regarding other issues that I raised, e.g., Germany, Alibra, et. al. Hope to hear something tomorrow, or some time next week. I'll post it when I receive it. Question: can anybody out there tell me how to post an e-mail response to this thread - in layman's terms? I'm using Windows 98. Regards to all. |
